Segregation analysis in nonsyndromic holoprosencephaly.

Holoprosencephaly. Orphanet J Rare Dis (2007) 2.63

Paternal factors and schizophrenia risk: de novo mutations and imprinting. Schizophr Bull (2001) 1.75

Wide phenotypic variability in families with holoprosencephaly and a sonic hedgehog mutation. Eur J Pediatr (2004) 1.18

New findings for phenotype-genotype correlations in a large European series of holoprosencephaly cases. J Med Genet (2011) 1.04

Clinical characterization of individuals with deletions of genes in holoprosencephaly pathways by aCGH refines the phenotypic spectrum of HPE. Hum Genet (2010) 1.03

Holoprosencephaly: recommendations for diagnosis and management. Curr Opin Pediatr (2010) 1.02

Sonic hedgehog mutations identified in holoprosencephaly patients can act in a dominant negative manner. Hum Genet (2008) 0.91

Holoprosencephaly: a guide to diagnosis and clinical management. Indian Pediatr (2011) 0.83

Middle Interhemispheric Variant of Holoprosencephaly - Presenting as Non-Visualized Cavum Septum Pellucidum and An Interhemispheric Cyst in A 19-Weeks Fetus. J Clin Diagn Res (2015) 0.75

Molecular analysis of holoprosencephaly in South America. Genet Mol Biol (2014) 0.75

Conservation of the Caenorhabditis elegans timing gene clk-1 from yeast to human: a gene required for ubiquinone biosynthesis with potential implications for aging. Mamm Genome (1999) 9.96

Effects of misspecifying genetic parameters in lod score analysis. Biometrics (1986) 6.36

Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet (1997) 6.08

Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta (1994) 4.93

Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J Med Genet (2006) 4.64

Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet (1997) 4.26

Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet (2007) 4.13

Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature (1994) 4.04

X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86

Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature (2000) 3.61

Retinal-specific guanylate cyclase gene mutations in Leber's congenital amaurosis. Nat Genet (1996) 3.51

Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet (1997) 3.37

Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature (1994) 3.33

Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12-q14. The French Spinal Muscular Atrophy Investigators. Lancet (1990) 3.12

Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet (1995) 3.09

Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome. Lancet (1989) 2.98

Linkage detection by the Affected-Pedigree-Member method: what is really tested? Genet Epidemiol (1993) 2.88

A second locus for Marfan syndrome maps to chromosome 3p24.2-p25. Nat Genet (1994) 2.71

Mutant WD-repeat protein in triple-A syndrome. Nat Genet (2000) 2.54

Leber congenital amaurosis. Mol Genet Metab (1999) 2.52

19q13.11 deletion syndrome: a novel clinically recognisable genetic condition identified by array comparative genomic hybridisation. J Med Genet (2009) 2.37

P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer (2000) 2.35

SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nat Genet (1998) 2.30

Clinical and genetic heterogeneity in retinitis pigmentosa. Hum Genet (1990) 2.26

In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J Med Genet (2003) 2.26

A frame-shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients. Nat Genet (1995) 2.24

Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet (2005) 2.24

Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet (1999) 2.23

Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet (1999) 2.18

Structure and organization of the human survival motor neurone (SMN) gene. Genomics (1996) 2.12

Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology (2012) 2.12

Congenital lumbosacral lipomas. Childs Nerv Syst (1997) 2.11

The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol (1998) 2.04

Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat Genet (1996) 2.01

Analysis of mtDNA variant segregation during early human embryonic development: a tool for successful NARP preimplantation diagnosis. J Med Genet (2005) 2.00

Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes. Hum Mol Genet (2001) 2.00

A gene for hereditary multiple exostoses maps to chromosome 19p. Hum Mol Genet (1994) 2.00

Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet (2000) 2.00

Spectrum of ABCR gene mutations in autosomal recessive macular dystrophies. Eur J Hum Genet (1998) 1.97

X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet (1994) 1.97

Denaturing high-performance liquid chromatography (DHPLC)-based prenatal diagnosis for tuberous sclerosis. Prenat Diagn (2001) 1.95

BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. Am J Hum Genet (1997) 1.91

Genetic study of nonsyndromic coronal craniosynostosis. Am J Med Genet (1995) 1.88

Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet (1997) 1.84

FGFR2 mutations in Pfeiffer syndrome. Nat Genet (1995) 1.82

Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. J Med Genet (2005) 1.80

A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10. Nat Genet (1993) 1.79

Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet (2001) 1.77

Autosomal dominant Marfan-like connective-tissue disorder with aortic dilation and skeletal anomalies not linked to the fibrillin genes. Am J Hum Genet (1993) 1.74

Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC) J Clin Invest (2000) 1.72

Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet (1998) 1.72

CpG dinucleotides are mutation hot spots in phenylketonuria. Genomics (1989) 1.70

Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet (2000) 1.68

CHARGE syndrome: report of 47 cases and review. Am J Med Genet (1998) 1.68

Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet (1995) 1.68

Conclusions of segregation analysis for family data generated under two-locus models. Am J Hum Genet (1993) 1.67

Clinical and molecular heterogeneity of phenylalanine hydroxylase deficiencies in France. Am J Hum Genet (1988) 1.66

7q11.23 deletions in Williams syndrome arise as a consequence of unequal meiotic crossover. Am J Hum Genet (1996) 1.64

A mutation in the human heme A:farnesyltransferase gene (COX10 ) causes cytochrome c oxidase deficiency. Hum Mol Genet (2000) 1.62

Genitopatellar syndrome: a new condition comprising absent patellae, scrotal hypoplasia, renal anomalies, facial dysmorphism, and mental retardation. J Med Genet (2000) 1.62

Central nervous system malformations and early end-stage renal disease in oro-facio-digital syndrome type I: a review. Am J Med Genet (1998) 1.62

Autosomal dominant familial spastic paraplegia is genetically heterogeneous and one locus maps to chromosome 14q. Nat Genet (1993) 1.60

Clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum Mol Genet (1997) 1.59

Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children. Transplantation (2001) 1.59

Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum Mol Genet (1995) 1.59

Molecular genetics of phenylketonuria in Mediterranean countries: a mutation associated with partial phenylalanine hydroxylase deficiency. Am J Hum Genet (1989) 1.58

Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome. Hum Genet (2000) 1.56

Complete exon-intron structure of the RPGR-interacting protein (RPGRIP1) gene allows the identification of mutations underlying Leber congenital amaurosis. Eur J Hum Genet (2001) 1.55

A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat Genet (2001) 1.55

A gene for X-linked idiopathic congenital nystagmus (NYS1) maps to chromosome Xp11.4-p11.3. Am J Hum Genet (1999) 1.54

Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families. J Med Genet (2008) 1.53

Expression of the Sonic hedgehog (SHH ) gene during early human development and phenotypic expression of new mutations causing holoprosencephaly. Hum Mol Genet (1999) 1.53

Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest (1998) 1.52

High incidence of SHOX anomalies in individuals with short stature. J Med Genet (2006) 1.51

Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). Hum Mol Genet (1996) 1.50

Incomplete penetrance and expressivity skewing in hereditary multiple exostoses. Clin Genet (1997) 1.49

Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease. Nat Genet (1996) 1.49

Sulphate transporter gene mutations in apparently isolated club foot. J Med Genet (2001) 1.47

Efficiency of metabolic screening in childhood cardiomyopathies. Eur Heart J (1998) 1.46

Unexpected high frequency of skeletal dysplasia in idiopathic short stature and small for gestational age patients. Eur J Endocrinol (2014) 1.46

Strategies based on marker information for the study of human diseases. Ann Hum Genet (1992) 1.45

Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease. Hum Mol Genet (1995) 1.45

Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency. J Clin Invest (1994) 1.45

Heredity of idiopathic haemochromatosis: a study of 106 families. Clin Genet (1977) 1.44

Spectrum of retGC1 mutations in Leber's congenital amaurosis. Eur J Hum Genet (2000) 1.44

Dependence of hepatocyte-specific gene expression on cell-cell interactions in primary culture. EMBO J (1985) 1.44

Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia. J Biol Chem (1998) 1.43

Valproate-induced hepatic failure in a case of cytochrome c oxidase deficiency. Eur J Pediatr (1994) 1.43